nordic nordic congress 2020 brochure.pdftechnology innovators driving the future of healthcare. now...

Live and on-demandpanels

Thought leadership opportunities

Strategy, investment & networking

Access to a mix of live and on-demand content

1-4 September 2020

3rd Annual Conference

www.lsxleaders.com/nordic #lsxnordic @lsxleaders

Created by

STRATEGY, I NVESTMENT, PARTNERING AND DEAL M AKING FOR L IFE SC IENCE

EX ECUTIVE LEADERS

NORDICCONGRESS

VIRTUAL

http://www.lsxleaders.com/lsx-usa-congress

LSX Nordic Congress 1-4 September 2020

www.lsxleaders.com/nordic

The LSX Nordic Congress is a high-calibre, senior executive conference and partnering event designed to bring international investment and strategic partners for Nordic life companies to the region. The Nordic region has long produced world-leading science and innovation and the LSX Nordic Congress will be all about showcasing this innovation, both of the region’s industry leaders but also through start-ups and technology innovators driving the future of healthcare. Now in its third year, and delivered digitally, the online experience features everything from the physical event and more! Hear from, connect, network and schedule 1:1 meetings with the leading lights and most exciting startups in life sciences from across the Nordics, as well as global investors and partners!

LSX Nordic Congress VirtualWhat is it and who is it for?

What is a virtual experience?



Social distancing practices around the world have shown just howproductive digital work methods can be, and we are confident LSX Nordic Congress Virtual will deliver equal if not even greater, value as attending the physical event.

Across four days you’ll be able to:

• Access a mixture of live interactive panels and on-demand debates and discussions; dip in and out of the content sessions and watch at times that suit your partnering schedules so you never miss a thing.

• Schedule and take 1:1 video meetings and network with hundreds of Nordic life science executives, global and investors and partners from the comfort of your office or home workspace.

• Participate in live interactive forums with your peers and expert-led workshops!

• Dive into an exciting library of company showcases from the most innovative life sciences companies and budding startups

Don’t just think of it as an online physical event, think of it as a brand-new virtual experience!

LSX Nordic Congress Virtual offers three different content formats in which enjoy the sessions on offer: LIVE = Real-time content with audience Q&A (becomes on-demand once held)

ON-DEMAND = Evergreen content that can be watched anytime to fit around your schedule

INTERACTIVE = Live, peer-to-peer grouped sessions allowing multi-way discussion

http://www.lsxleaders.com/usa


Key SpeakersLSX Nordic Congress 1-4 September 2020


Ingrid Akay Managing PartnerHadean Ventures

Adam Kostyál SVP, Nasdaq

Phil L’HullierHead of BD, Europe, European Innovation HubMSD

Thierry Laugel Managing PartnerKurma Partners

Andreas Jurgeit Partner,Lundbeckfonden

Stephan Christgau Partner,Eir Ventures

Patrik SobockiInvestment ManagerIndustrifonden

Klaus Stöckemann Managing PartnerPeppermint Venture Partners

Karl XavierPartnerAxilium Capital

Sascha Alilovic Partner, SHS

Gunilla Osswald CEO, BioArctic

Don deBethizy Director, Argenx

Karl Bergman CEO, Elypta

Martin Åmark CEO, Xbrane Biopharma

Carsten Borring AVP, Listings EMEA and Head of Listings & Capital Markets, NASDAQ

Ingalill Hyltander Commercial Operation Director Pharma Scandinavia, Bayer

Maria Tell Investment Manager, Almi Invest

Mats Berggren Director, Digital Business Innovation & External Collaboration Models, M-Digital Lead, Merck KGaA

Nikolaj Sørensen CEO, Orexo

Ulrica Slåne Bjerke CIO, Arctic Aurora LifeScience

Carsten Kjær Joensen Head of Office for Life Sciences, Government Offices of Denmark

Magnus Corfitzen CEO, Ascelia Pharma

Renée Aguiar-Lucander CEO, Calliditas Therapeutics

Jenni NordborgHead of the Office for Life Sciences, Government Offices Sweden



Congress PartnersHost Sponsor

Gold Sponsors

Media & Supporting Partners

Silver Sponsors

Associate Partners

Bronze Sponsors

Thomas Lönngren Strategy Advisor, NDA Group and former Head of EMA



Agenda at a glance1-4 September 2020LSX Nordic Congress


Agenda at a glance1-4 September 2020LSX Nordic Congress


LIVE: KEYNOTE ADDRESS–THE FUTURE OF DANISH LIFE SCIENCES STRATEGY

09:05

LIVE: PUBLIC CEO FORUM

ON DEMAND PANEL: WHAT’S HOT IN EARLY STAGE INVESTMENT?

1:1 PARTNERING (available all-day)

LIVE KEYNOTE PANEL: COMING OUT THE OTHER SIDE: PERSPECTIVES ON LIFE SCIENCE STRATEGIES, PRIVATE AND PUBLIC FINANCING, PARTNERSHIPS AND M&A IN THE AFTERMATH POST-COVID-19

Day 1 Day 2

11:00

13:00

LIVE PANEL: GLOBAL SYNDICATION AND EXPANDING YOUR INTERNATIONAL INVESTOR BASE

16:00

CLOSE16:45

ON DEMAND KEYNOTE PANEL: INVESTING IN HEALTHTECH & DIGITAL HEALTH - THE NEXT WAVE OF NORDIC INNOVATION

Day 3 Day 4

11:00

ON-DEMAND SHOWCASES (available all-day)09:00

10:30

LIVE: PRIVATE CEO FORUM (1 hr 45 mins)14:00

09:15

16:00

16:45

PRESENTATION: DEVELOPMENT WITH THE END IN MIND - HOW TO BRIDGE THE “VALLEY OF DEATH”

10:15

12:45DRIVING SHAREHOLDER VALUE THROUGH EFFECTIVE PARTNERSHIPS

LIVE: DEVELOPING AND OPTIMISING PHARMA PARTNERSHIPS ACROSS BIOTECH, MEDTECH AND HEALTHTECH INNOVATION

CLOSE

1:1 PARTNERING (available all-day)10:00


ON DEMAND: ALL PANELS (available all-day)

ON-DEMAND SHOWCASES (available all-day)

09:00


ON DEMAND: ALL PANELS (available all-day)

ON-DEMAND SHOWCASES (available all-day)

09:00

09:0009:00

09:00 09:00

*All times in CEST (GMT - 1hr)


LIVE: KEYNOTE ADDRESS – THE FUTURE OF SWEDISH LIFE SCIENCES STRATEGY

09:20

LIVE: JOINT Q&A09:35

LIVE: OPENING PANEL:CULTIVATING A SUSTAINABLE ECOSYSTEM AND COMPANIES WITH LONG-TERM AMBITIONS IN THE NORDICS

10:00

15:00LIVE: DEVELOPING AND OPTIMISING PHARMA PARTNERSHIPS ACROSS BIOTECH, MEDTECH AND HEALTHTECH INNOVATION



2020 Investors & Pharma BDLSX Nordic Congress 1-4 September 2020


INVENTING FOR LIFE

2020 Investors & Pharma BDLSX Nordic Congress 1-4 September 2020




Full Agenda1-4 September 2020LSX Nordic Congress


11:00LIVE: Public CEO Forum (Zoom)

Co-hosted by:

Moderator: Don deBethizy, Director, Argenx

Nordic and Global Capital Market Outlook Adam Kostyal, SVP, Head of European Listings, Nasdaq Peter Legind-Hansen, MD, Nasdaq

Conference - 1 September09:00

LSX & Nasdaq Welcome Josh Dance, SVP, LSX Adam Kostyál, SVP, Nasdaq

10:00LIVE: Opening Panel: Cultivating a sustainable ecosystem and companies with long-term ambitions in the Nordics Key stakeholders from across the region discuss how the Nordic ecosystem is evolving and what more can be done to finance, invest and build the Nordic cluster with a great proportion of larger companies with long-term ambitions, to complement and support the thriving startup and growth stage community.

• What does it take to build large and internationally competitive companies? Do enough have the long-term ambitions?• Which policy, regulation and industry initiatives can help build upon the exceptional life science leadership and innovation and work towards an even more internationally competitive hub and the growth of $billion businesses?• How, and in which ways, can Government strategy and support help shape and build the Nordic life sciences cluster?• What are the key success factors for companies in internationalisation and finding global investors, partners and advisors?

Moderator: Bobby Soni, CBO, Novo Nordisk BII Nikolaj Sørensen, CEO, Orexo Magnus Corfitzen, CEO, Ascelia Pharma Jenni Nordborg, Head of the Office for Life Sciences, Government Offices of Sweden Adam Kostyál, SVP, Nasdaq

LIVE: Keynote Address – The Future of Danish Life Science Strategy • Providing an update on the 2018 Life Sciences Growth Plan• Progress on the 36 initiatives put in place to target barriers and capitalise on opportunities across the value chain for the Danish Life Sciences Industry across the value chain• How and in what ways has the covid-19 pandemic affected the sector?

Carsten Kjær Joensen, Head of the Office for Life Sciences, Government Offices of Denmark

09:05

LIVE: Keynote Address – The Future of Swedish Life Science Strategy • Outlining the core components of the new Life Sciences Strategy• How will Sweden work to attract and maintain life science companies and strengthen home-grown companies’ abilities to grow and meet global healthcare demands?• How and in what ways will the new strategy and roadmap be implemented?

Jenni Nordborg, Head of the Office for Life Sciences, Government Offices of Sweden

09:20

LIVE: Joint Q&A Carsten Kjær Joensen, Head of the Office for Life Sciences, Government Offices of Denmark Jenni Nordborg, Head of the Office for Life Sciences, Government Offices of Sweden Josh Dance, SVP, LSX

09:35

Pre-Day IPO Bootcamp1-4 September 2020LSX Nordic Congress


LIVE: THE CURRENT STATE OF THE NORDIC IPO MARKET09:00

LIVE ROUNDTABLE: DETERMINING AND DEFINING YOUR IPO STRATEGY

IPO CASE STUDY Magnus Corfitzen, CEO, Ascelia Pharma

1:1 EXPERT CONSULTATIONS: OVER ZOOM CALLS

09:20

10:00

CLOSE17:00

11:00

In line with our mission to support funding, financing and deal making in the sector, LSX teaming up with some of the regions foremost experts, advisers, bankers and consultants to help CEOs and CFOs navigate the how, what, where and when of a successful IPO on Nasdaq Nordics. The Bootcamp runs as part of the 3rd annual LSX Nordic Congress, delivered virtually.

The Nordic IPO Bootcamp is an invitation only online forum, workshop, and series of digital 1-2-1 video meetings. It provides CEOs and CFOs of life science companies contemplating an IPO a unique opportunity to come together for a series of frank and open discussions with peers, case studies from executives who have recently been through the process, and for tailored and 1-2-1 advice with the region’s foremost experts, advisers, bankers and consultants.

*Bootcamp by invitation only. If you are interested in a seat at the bootcamp message [email protected]


Co-hosted by:

Keynote Panel: Investing in Healthtech & Digital Health - The next wave of Nordic innovation Healthtech and digital health technologies are starting to realise their promise and make meaningful impacts across the life science and healthcare space, and the Nordic countries are among Europe’s leaders in the digital healthcare revolution. Investors and executives discuss the local and international investment landscape in digital and health technology and how the Nordics can lead the way in innovation.

• How quickly could Nordic healthtech innovation grow to match medtech and biotech expertise?• The region already boasts some exciting digital health success stories; is innovation in this area continuing to grow and how are investors seeing digital investment opportunities compared to more traditional investments?• The covid-19 epidemic has expedited the digitisation the healthcare sector and validated its necessity; how are investors evaluating these opportunities as necessity in which specific technologies has the acceleration been most evident, and how do you pick the future winners? Moderator: Kathrine Myhre, CEO, Norway Health Tech Patrik Sobocki, Investment Manager, Industrifonden Klaus Stöckemann, Managing Partner, Peppermint VP Andreas Lindblom, CEO, Sciety

11:00



mailto:Josh%40lsxleaders.com?subject=


Conference - 2 September


12:45Driving shareholder value through effective partnerships Partnering up with big pharma or other life science companies can make cost savings and pool resources and expertise, but for public companies are not without risk. Executives of public companies with licencing, co-development and R&D partnerships share their stories of securing these deals and discuss effective deal structures, mitigating risks in asset dilution and commercialisation rights and how to drive shareholder value through optimising these partnerships.

• Balancing partnerships with further capital raises for pipeline development; what are the long term affects on stock price?• What are the most effective deal structures for public companies entering partnerships?• How can you ensure deals are transformative for company growth whilst retaining value for shareholders? Moderator: Jan de Kerpel, Managing Director, Kempen Gunilla Osswald, CEO, BioArcticDon deBethizy, Director, Argenx Renée Aguiar-Lucander, CEO, Calliditas Therapeutics



16:00LIVE: Developing and optimising pharma partnerships across biotech, medtech and healthtech innovation

The potentially transformative nature of partnership a big pharma is well documented but is not without its risks and challenges and partnerships and deals differ between private and public companies. Pharma continue to be hungry to source innovation and build win-win partnerships with the latest technologies to supplement and complement internal R&D. Heads of innovation, search and evaluation and business development from big Pharma discuss the role pharma companies are taking in supporting younger companies and the evolving strategies in all life science and technology partnerships and deals.

• Will the trend of private rounds in place of IPOs in Europe for European companies continue?• Will increasing interest from American and Asian funds lead to more competitive tension for deals in Europe? • How can companies, and how will investors, be getting out and connecting internationally in the new normal? Moderator: Thomas Lönngren, Strategy Advisor, NDA Group and former Head of EMAPhil L’Huillier, Head of BD, Europe, European Innovation Hub, MSD Ingalill Hyltander, Commercial Operation Director Pharma Scandinavia, BayerMats Berggren, Director, Digital Business Innovation & External Collaboration Models, M-Digital Lead, Merck KGaA Nerida Scott, Head of Johnson & Johnson Innovation EMEA, Johnson & Johnson

16:45Close of Day 2 Content - Partnering Continues

13:00What’s hot in early stage investment? Expert early-stage investors highlight where they see the exciting and hot new areas in life sciences investment. They will also debate how smaller can compete with larger funds dominating increasingly larger series A rounds, and if we see an even greater focus on early syndication from smaller players, particularly post-covid. • The Nordic early-stage startup ecosystem is booming–in which areas is there most excited and where is the early capital currently going? • How are smaller funds competing with larger local and international funds? Will we see ever greater syndication in early deals? • Is there enough support and local capital for early-stage innovation to be funded and thrive? Karl Xavier, Partner, Axilium CapitalAndreas Jurgeit, Partner, Lundbeckfonden Emerge Ingrid Akay, Managing Partner, Hadean Ventures Maria Tell, Investment Manager, Life Sciences, Almi Invest

14:00LIVE: Private CEO Forum (Zoom)

Co-hosted by:


16:00LIVE: Panel: Global syndication and expanding your international investor base

With new Nordic and European life science funds emerging, long term specialists recharging and new players and capital from Asia and the Middle East, as well as the US, increasingly entering into deals, global syndication in the healthcare space is reforming the investment landscape. Investors discuss how the Nordic region, as a leading European hub for new science and innovation, and the companies from it can access, build and leverage an international investor base.

• Will the trend of private rounds in place of IPOs in Europe for European companies continue? Do the strong Nordic public markets factor into investment decisions?• Will increasing interest from American and Asian funds lead to more competitive tension for deals in Europe?• How can companies, and how will investors, be getting out and connecting internationally in the new normal?

Moderator: John Rudy, Member, MintzStephan Christgau, Partner, Eir Ventures Rachel Mears, Partner, Jeito Thierry Laugel, Managing Partner, Kurma Partners Sascha Alilovic, Managing Partner, SHS Petros Farah, Vice President, Vickers Venture Partners

16:45Close of Day 1 & Virtual Drinks - Partnering Continues

09:15LIVE: Keynote Panel: Coming out the other side: Perspectives on life science strategies, private and public financing partnerships and M&A in the aftermath post-Covid-19 The COVID-19 outbreak has sent shockwaves through the world, disrupting every industry and creating uncertainties in financial markets. The life sciences and healthcare is in a unique position with some companies pivoting to help in the fight against the virus, others business plans being severely disrupted, and both public and private investors in the sector navigating an untrodden path. A cross-stakeholder panel discusses • What has been the impact on investors portfolio companies, investment strategies and appetite in the short and medium term?• How and where will changes in the public and private capital available to companies affect wider industry M&A activity?• Could Pharma partnering strategies change? How can companies best position themselves to come out stronger? Moderator: Chris Maggos, Managing Director, Head of Europe, LifeSci Advisors Ulrica Slåne Bjerke, CIO, Arctic Aurora LifeScience Benedicte Bakke, Portfolio Manager, DNB Asset Management Søren Moller, Managing Director, Novo Seeds Mario Augusto Maia, Head of Investments, Novozymes

Case Studies

Nordic and Global Capital Market Outlook Adam Kostyal, SVP, Head of European Listings, Nasdaq Peter Legind-Hansen, MD, Nasdaq Accessing US Capital & Partners Chris Jeffers, Member, Mintz Raising Capital During COVID-19 Patric Stenberg, CEO, Gesynta

11:00LIVE: Public CEO Forum (Zoom)

Co-hosted by:

Key Legal Trends and Highlights Erik Sjöman, Partner, Vinge Dain Hård Nevonen, Partner, Vinge Biotech Going Digital Nikolaj Sørensen, CEO, Orexo

10:15Presentation: Development with the end in mind - how to bridge the “valley of death” • Common threats for a startups and how to mitigate them• Developing an integrated strategy for efficient pharmaceutical development• Strategies to bridge the valley of death Anders Nyholm, Director Life Science Consulting, ProPharma Group

15:00LIVE: Nasdaq Nordic listing and cross trading on the US OTC Markets: Creating a global trading solution for investors and opportunity for Nordic companies Reaching American investors is usually always a big focus for life sciences companies, be that for private or public investments. What are the best strategies for gaining access and exposure to American capital? The panel discusses:

• When should a company consider cross-trading on the US OTC Markets?• How does OTC Markets and Nasdaq Nordics businesses complement each other and what does this mean for Nordic issuers?• What are the benefits of gaining access and exposure to American investors through the secondary US OTC market?• From the company perspective, what can this exposure mean for your business? How can cross trading increase volume and liquidity on the local exchange due to greater access to US investors? Moderator: Joe Coveney, Vice President, OTC MarketsLena Wange, Head of Investor Relations, OrexoAdam Kostyal, SVP, Nasdaq







All live and on-demand panels available on-demand

1:1 Partnering (All Day) On Demand Showcase Videos (All Day)

ALL DAY

All live and on-demand panels available on-demand

1:1 Partnering (All Day) On Demand Showcase Videos (All Day)

ALL DAY

To maximise the opportunity for international 1:1 partnering in the virtual format, across multiple timezones and working around work commitments and schedules, the event and partnering system will remain live for the full week! What’s more, to ensure you have the chance to view all of the panel discussions, keynote sessions and showcases of the most exciting and innovative companies the Nordic region has to offer, these will all be available on-demand for the rest of the week too!

ShowcasesLSX Nordic Congress 1-4 September 2020


The virtual experience showcases all stages of private and public biotech, medtech and healthtech companies from across the Nordic Region.

Companies have the opportunity to pre-record and release on-demand video showcases alongside their profiles and relevant supporting documentation for investors and partners to search, evaluate and connect. Showcases will remain available on-demand for the full four-day experience.

Companies have the opportunity to utilise a virtual booth to stream / broadcast additional content that sits along side live chat functionality to help demonstrate products/technology in realtime.

When is showcasing and a virtual tech booth a good idea:

• When you are actively fundraising or looking to attract partners• When you have impactful company or product news• When you are raising awareness of your business or new developments in your pipeline or

commercial development



Confirmed ShowcasesLSX Nordic Congress 1-4 September 2020


1:1 PartneringLSX Nordic Congress 1-4 September 2020


LSX is committed to foster collaboration among all virtual conference attendees. Our goal is for you to establish new partnerships, and find the best connections possible even when face-to-face is not possible.

Video and audio-enabled partnering is delivered through this web-based content platform which allows the pre-arrangement of video-conference meetings 2 weeks from the event and for the duration of the four days.

Swapcard is an powerful AI-driven matchmaking platform, meaning the stress of finding likeminded executives is removed when using this automated software. Complete your profile in full and Swapcard will AI-match with registered delegates, presenting you with a rated list of executives aligned to your search criteria from most relevant to least relevant. You can still search the full list of participants alongside this automated process should you wish to expand your outreach to other profiles.

Registered attendees will be able to access their own personal schedule, search attendees’ profiles, request and reschedule meetings with other executives and connect for private and secure 20min video conferencing.1:1 Partnering runs 24hrs to accommodate all time zones and kicks off from 10am CET on Day 1. We also realise that some of the most valuable connections happen through serendipitous and chance meetings. For this reason there will be several dedicated networking receptions built in to the virtual schedule each day allowing you to engage in live text chat or 3min speed networking-style video calls with other online attendees, before deciding if you’d like to arrange a more formal meeting through the partnering system.



1-4 September 2020LSX Nordic Congress


2019 Attendee BreakdownThe LSX Nordic Congress grow significantly in the second year, in terms of the overall numbers and diversity of the delegation, the international investor attendance, and with a showcase of some of the most exciting life science and healthcare companies the region has to offer; from the newest innovative start-ups to the region’s leading public corporates.

These stats highlight the diversity of the audience.



2019 Companies Breakdown

86%

4%5% 5%

Company Attendee Seniority

C-Level / President / Board Level / Founder

SVP / EVP / VP

Head / Manager

Director





2019 Investor Breakdown 2019 Attendee Summary

LSX Nordic Congress 1-4 September, 2020


Chief Executive Officer, 2A PharmaChief Business Officer, 2cureXChief Operating Officer, 2N PharmaPartner, 4BIO CapitalInvestment Director, 4BIO CapitalCEO, A1M Pharma COO, Aasa Health AB - “Träning på Recept”Partner, ABG Sundial ColliarCEO, AblyCEO, AbomicsCEO, Active BiotechAngel, ActivebizCEO, AddBIOChairman, AddBIOPartner, Advokatfirman DelphiCEO, AffibodyCEO, Age LabsInvestment Manager, Almi InvestSenior Financial Advisors, Alpha Blue OceanChief Executive Officer, Annexin PharmaceuticalsCSO, AnoccaChief Executive Officer & Scientific Founder, AnoccaCEO, AplagonCEO, ApoglyxFounder, PM, ArcticChief Executive Officer, ArocellChief Executive Officer, Ascelia PharmaFounder and CEO, Asgard TherapeuticsCEO, AtrogiCFO, Avia PharmaPartner European Patent Attorney, AWA SwedenCEO, AZ BioVentureHubFounding Partner, BedrockCEO, BerGenBioCOO, Biomedical BondingCEO, Biomedical BondingCEO, BiomodicsCEO, Bioservo TechnologiesCEO / EDITOR, BioStockCEO, BrainCoolPrincipal, Bridge Valley VenturesCEO, Calliditas TherapeuticsChief Executive Officer, CantargiaCEO, CardiaccsDirector, Business Development, CelerionCo founder + CFO, CerenionCEO, Cereno ScientificDirector of Business Development, Clinical Reserach Services Turku-CRSTCEO, CLSproject manager, Connect UppsalaClient Partner, Coulter PartnersCEO, CytovacCEO, DesentumPresident & CEO, Diamyd MedicalCFO, Diamyd MedicalCEO, DicotBoard Member, DicotCEO, DilaforChief Commercial Officer, Dyadic InternationalChief Executive Officer, Elypta

CEO, Endovascular DevelopmentManaging Director, EstBANCEO, EVMPartner, Head of Corporate Finance and Life Sciences Nordics, EYPartner, EYVP, Financing and Investor Relations, Faron PharmaceuticalsAssociate, ForbionCEO, Gedea BiotechCEO, Genagon TherapeuticsChief Operating Officer, Genagon TherapeuticsSenior Investment Manager / Vice President Business Development, Global Core MedicalChief Executive Officer, GlucoSetNational Coordinator Life Sciences, Government Offices of SwedenDigital Media Director, Guided SolutionsCEO, Guided SolutionsManaging Partner, Hadean VenturesPartner, Hadean VenturesPartner, HBM PartnersPartner, HealthCapInvestment Associate, HealthCapChief Executive Officer, Herantis Pharma PlcPatent Director, HGFCEO, Hy5Associate, Illumina VenturesCEO, ImmunicumChief Executive Officer, ImmunoviaCEO, ImmunscapeInvestment Manager, IndustrifondenVenture investor, IndustrifondenCEO, InfiCure BioDirector of Innovation, Innovation SkaneCEO, Inorbit Therapeutics abInvestment Director, InventureInvestment Director, InvestinorSenior Associate, InvestinorPartner, IPF PartnersBusiness Development Director, IQVIAAssociate Director, IQVIABD Director, IQVIAGeneral Partner, Joint Polish Investment fundGeneral Partner and Chairman, JulzAngel, Karolina VenturesDirector, Kempen CEO, KIRAMVice President, Kreos CapitalFounder, Ktisis BioDirector, LavivoCEO, LavivoCEO, Lind Growth StrategyCEO, Longboat AmnioticsExecutive Vice President, LU HoldingPortfolio Manager, LU HoldingConsultant, LucyJRobertshawPartner, Lundbeckfonden EmergeCEO, LyfstonePartner, MAKI.VCCEO, Meabco



2019 Attendee SummaryLSX Nordic Congress 1-4 September, 2020


CSO, MeabcoCEO, MedbeatChief Executive Officer, MedeonPresident, MedVASCHealthcare Reporter, MergermarketCo-chair, Life Sciences Practice Group, Mintz Levin Cohn, Ferris, Glovsky and Popeo, P.C.CEO, Modus TherapeuticsVD, Monica Hedberg InvestCEO, MonidorExecutive Director, Oncology, MSDInvestment Partner, MTIPEuropean BD&L Manager, MundipharmaSenior Managing Director EMEA, NasdaqDirector, NasdaqStrategy Advisor, NDA GroupCEO, Nordic NanovectorHead of Communication, Norway HealthtechManaging Partner, Novo Seeds, Novo HoldingsAssociate, Novo HoldingsVP of Search & Evaluation, Novo NordiskCEO, NuevolutionCBO, deputy CEO, Oasmia PharmaceuticalsCEO, OcusweepCEO, OmnioCEO & Founder, Oncology VentureChief Operating Officer, Oncology VentureVP Business Development, Oncology VentureChief Executive Officer, OnDosisDirector, Optimum Strategic CommunicationsPrincipal, Optum VenturesCEO, OtivioCEO, PanCryosCCO, Particle3DCEO, Particle3DCTO, Particle3DEuropean Lead Worldwide Business Development, PfizerPartner, Potter ClarksonAssociate, Potter ClarksonSenior PPD Consulting Director, PPDSenior Account Director, PPDCFO, Primex PharmaceuticalsGroup CEO, Primex PharmaceuticalsCEO, ProkariumFounder, R VenturesChairman of the Board, Reccan DiagnosticsEVP, Red Glead DiscoveryCEO, Resorbable DevicesCEO, ResoTher Pharma ApSCEO, RespinorCBO & Deputy CEO, RhoVacPM, RhoVacFounding Director, Rigi CareCEO, SAGA DiagnosticsDirector, Finance, SAGA DiagnosticsChair, Board of Directors, SanionaCFO, Saniona

Partner, Sarsia FundManaging Director, SBA Ltd (on behalf i2020 Accelerator)CEO, Scandion OncologyCEO, ScietyInvestment Manager, ScietyHead of Equity Sales, Sedermera FondkommissionChairman, SenzagenChief Executive Officer, SenzagenPartner, Serendipity partnersCOO, Serodus ASAChief Executive Officer, Serodus ASAPartner, SHS CapitalBusiness Development, SmiLe IncubatorManaging Partner, Sofinnova PartnersCEO, Spago NanomedicalProgramme and Partnerships Manager, Start CodonStartUp Health Ambassador, Europe & Israel, StartUp Health IncManaging Director, StifelCEO, SubcujectManaging General Partner, Sunstone Life Science VenturesCEO & Co-Founder, Surgify MedicalPM, Swedbank RoburChief Executive Officer, Swedish Orphan BiovitrumHead of Communications, Swedish Orphan BiovitruviumManager Swelife International, SwelifePA to CEO, SymphogenChief Executive Officer, Symphogen Sr Director Business Development, SynteractInvestment Manager, TesiCEO, TFSAnalyst, TillväxtanalysPrincipal, Europe, TRINITY Life SciencesCEO, UmanSenseBusiness coach, Umeå Biotech IncubatorAngel, Uppsala BiotechSenior Advisor, Uppsala Innovation CentreCEO, Uppsala universitet HoldingInvestment director, VækstfondenCBO, Valo TherapeuticsHead of R&D, Valo TherapeuticsChief Operating Officer, VAR2 PharmaceuticalsChief Executive Officer, VetokCFO, Vicore PharmaChief Executive Officer, Vicore PharmaPartner, VingePartner, VingePartner, Vitality in Aging Research GroupChief Executive Officer, Xbrane BiopharmaChief of innovation division, Zcube - Zambon research ventureCEO, Zora BiosciencesCOO, Zora Biosciences



Why Sponsor

For sponsor or exhibition enquiries contact:

Joe Knight, BD Manager, [email protected]

+44 (0) 20 7039 3408

The LSX Nordic Congress Virtual experience offers a limited number of opportunities for companies wishing to raise their profile, enhance their brand, demonstrate thought leadership and access and engage with leaders in Nordic life sciences and global investors and partners

We are presenting tremendous opportunities for top tier service companies who would see the congress as a platform to:

• Demonstrate thought leadership and position your organisation at the forefront of the exciting Nordic life sciences ecosystem

• Educate potential new clients and partners about your unique offering, service or solution

• Generate qualified business leads through bespoke, forums with high-calibre life science decision makers

• Be seen as an obvious partner of choice in your specified domain as this market grows

What can sponsorship of a virtual experience offer that a physical event cannot? • Reporting and tracking; receive stats and intel on who and how many engaged with your session / content through the four-day experience and beyond

• Longer interaction and more impressions; the virtual experience gives an additional 30-days of exposure to all content, meaning your sessions / content reach a far wider audience than just those present the day the experience was live

• A larger geographical pool of prospects; there will always be time limitations as to how many delegates can attend a physical event, a virtual event is more accessible

• Halve your costs; removing flight, hotel and subsistence costs from your budget massively reduces your budgetary spend and saves you time meaning you are more productive




Delegate Packages


For delegate enquiries contact:

Joe Knight, BD Manager, [email protected]

+44 (0) 20 7039 3408

14-Aug

Free

7600

FullPrice

2500

8900

Industry Tickets

Content Only Ticket

Investor Ticket + 1:1 Partnering

All...Tech Ticket + 1:1 Partnering

All...Tech Ticket + 1:1 Partnering+ Showcase + Virtual Tech Demo Booth Pharma Ticket + 1:1 Partnering

All Services Ticket + 1:1 Partnering

26-Jun 24-Jul

Free

5000

Free

6400

All prices are displayed in Swedish Krone (SEK).

7600 89005000 6300

11400 127008900 10100

11400 127008900 10100

Leading life science events1-4 September 2020LSX Nordic Congress

Free FreeFree Free

• Watch all the talks and panel discussions; Sessions are available to registered attendees live via an interactive experience and On-Demand

• Schedule 1:1 video partnering throughout the week with all attendees

• Join CEO Virtual Forums with your peers and workshops with industry experts

• The opportunity to record and deliver an online showcase to raise your company’s profile • Connect with attendees through live chat conversations

• Resources, reports and speaker presentations available for download

Pass Benefits

2-3 February 2021, 133 Houndsditch, London, UK www.lsxleaders.com/healthtech-leaders-2021

WORLDCONGRESS

2-3 February 2021, 133 Houndsditch, London, UK www.lsxleaders.com/world

5-6 May 2021, Business Design Centre, London, UK www.lsxleaders.com/healthspan

5-6 May 2021, Business Design Centre, London, UK

15-18 September 2020 Virtual Event www.lsxleaders.com/healthtech

HEALTHT CH LEADERSVIRTUAL PARTNERING & INVESTMENT

Contact us today to find out how to get involved in any or all of our events. www.lsxleaders.com/events

11-16 November 2020 Virtual Event www.lsxleaders.com/investival


mailto:matt%40lsxleaders.com%20?subject=

http://www.lsxleaders.com/healthtech-leaders-2021

http://www.lsxleaders.com/world

http://www.lsxleaders.com/healthtech

http://www.lsxleaders.com/investival

Live and on-demandpanels

Thought leadership opportunities

Strategy, investment & networking

Access to a mix of live and on-demand content

Contact Us

For speaker opportunities contact:

Josh Dance, [email protected] +44 (0)20 7039 3403

For sponsor and booking opportunities contact:

Joe Knight, BD [email protected] +44 (0)20 7039 3408

For press, media & marketing enquiries contact:

Paul Gilbertson, Marketing [email protected] +44 (0)20 7039 3405

Or visit us at www.lsxleaders.com/nordic

www.lsxleaders.com/nordic #lsxnordic @lsxleaders

Created by

mailto:josh%40lsxleaders.com?subject=

mailto:joe%40lsxleaders.com?subject=

mailto:[email protected]


http://www.lsxleaders.com/lsx-usa-congress

nordic nordic congress 2020 brochure.pdftechnology innovators driving the future of healthcare. now...

Documents